I'm not sure if you understand or read people like me who are suggesting a buyout is possible, but I speculate a buyout is possible for the exact opposite reason you mention - I think BOT is a buyout consideration precisely because of what BOT has to offer to big pharma! And BOT management have made no secret of the fact that BOT isfor sale for the right price! Just because the SP is in the teens today doesn't mean that's what a buyer may pay for BOT. But like I've said numerous times, if BOT gets sold - we win, if it goes to sales and distribution instead and develops its pipeline - we win (it'll just take a bit longer). I'm sending you peace and chill vibes.
Ann: Notification regarding unquoted securities - BOT, page-47
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
-0.005(1.59%) |
Mkt cap ! $563.4M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 33.0¢ | 31.0¢ | $1.731M | 5.443M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 606129 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 92444 | 5 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |